Ten posters at the Winter Clinical Hawaii and Maui Derm Conferences will showcase investigational data to expand treatment options for patients with atopic dermatitis and chronic hand eczema.
LEO Pharma is set to make waves at the 2024 Winter Clinical Hawaii and Maui Derm Conferences with a comprehensive showcase of clinical and real-world data. Investigators including Andrew Blauvelt, MD, MBA; Peter Lio, MD; and Amy Paller, MD, will be presenting findings on delgocitinib cream and tralokinumab-ldrm (Adbry) across 10 posters, offering an invaluable insight into the treatment landscape for chronic hand eczema (CHE) and atopic dermatitis (AD).1
Investigational Delgocitinib Cream Data
A significant portion of presentations will focus on investigational delgocitinib cream, a topical pan-Janus kinase (JAK) inhibitor currently in development for the treatment of moderate-to-severe chronic hand eczema in adults. The data will include a pooled analysis of the DELTA 1 (NCT04871711)and DELTA 2 (NCT04872101) phase 3 clinical trials, assessing the impact of delgocitinib cream on health-related quality of life through the Dermatology Life Quality Index (DLQI) in patients with moderate to severe CHE.
The 5 posters on delgocitinib cream will cover various aspects, including efficacy and safety in adults, patient-reported outcomes related to itch and pain, and systemic exposure in the phase 3 DELTA 2 trial.
Here are delgocitinib posters and presenters to look out for on the conference floor:
Tralokinumab Data Presentations
The other 5 posters will highlight tralokinumab-ldrm, a high-affinity human monoclonal antibody designed to inhibit the interleukin (IL)-13 cytokine, approved for the treatment of moderate-to-severe AD. Posters will specifically focus on both clinical and real-world results in adult and pediatric patients with moderate-to-severe AD. Noteworthy is a 6-month interim analysis of a real-world study in adult patients living in the US, exploring patient-reported quality of life outcomes related to itch, sleep, and treatment satisfaction.
Here are tralokinumab posters and presenters to look out for on the conference floor:
Connect With Us
Are you attending the 2024 Winter Clinical Hawaii or Maui Derm Conferences this month? We would love to talk to you and hear your insight on top pearls and takeaways you plan to put into practice! Email us at DTEditor@mmhgroup.com.
1. LEO Pharma presents data at 2024 Winter Clinical and Maui Derm Conferences. News Release. BioSpace. January 12, 2024. Accessed January 12, 2024. https://www.biospace.com/article/releases/leo-pharma-presents-data-at-2024-winter-clinical-and-maui-derm-conferences/